Tandemly Repetitive Proteins in Mycoplasmas

支原体中的串联重复蛋白

基本信息

  • 批准号:
    7540932
  • 负责人:
  • 金额:
    $ 31.18万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-12-15 至 2010-11-30
  • 项目状态:
    已结题

项目摘要

Mycoplasmas commonly produce diseases of considerable economic impact, yet little information is available concerning mechanisms of pathogenesis and effective methods of control are unavailable. Many mycoplasmas possess surface proteins with regions of identical tandem repeats, sometimes with 40 or more repeat units per protein. Such molecules are usually lipoproteins with the lipid moiety serving to anchor the protein to the membrane and the carboxyl tandem repeat region free to interact with host cells and molecules. These proteins are all subject to high-frequency size variation due to slipped-strand mispairing that result in gain or loss of repeat units. The functions of these repetitive proteins and the phenotypic consequences of size variation are unknown. In the murine pathogen Mycoplasma pulmonis, size variation in the Vsa proteins modulates the growth properties of the mycoplasma (colony size variation), hemadsorption, and susceptibility to complement lysis. Our long-range goals are to understand the pathogenic mechanisms of mycoplasmas. The goal of the current proposal is to study the functions and pathogenic significance of Vsa size variation. Many mycoplasmas including M. pulmonis possess an extracellular matrix. We propose that this matrix is composed of the Vsa proteins and serves to protect the mycoplasma from complement. Aim 1 is to examine the matrix by electron microscopy,to determine if it is composed of the Vsa proteins, and to determine whether it is a barrier to complement. The Vsa proteins may affect interactions between the mycoplasma and host cells, and whether Vsa modulates the susceptibility of the mycoplasma to phagocytosis will be examined in Aim 2. In Aim 3, the pathogenic significance of Vsa size variation will be studied by comparing the ability of cells that produce a large (many tandem repeats) or a small (few repeats) Vsa protein in respect to their ability to colonize and cause disease in immuno-competent and complement- deficient mice. The results of these studies will elucidate the role of highly repetitive proteins in mycoplasmal diseases. They will also provide insight into the functions of repetitive proteins in other microbes that are important to public health including the agents responsible for malaria, tuberculosis, and a variety of bacterial pneumonias. By understanding the role of repetitive proteins in the disease process, it is anticipated that improved measures to control the infections of these significant human pathogens will be developed.
支原体通常产生具有相当大的经济影响的疾病,但很少有信息是 关于发病机制和有效的控制方法是不可用的。许多 支原体具有具有相同串联重复区域的表面蛋白,有时具有40个或更多 每个蛋白质的重复单位。这样的分子通常是脂蛋白,其脂质部分用于锚 蛋白质的膜和羧基串联重复区自由地与宿主细胞相互作用, 分子。这些蛋白质都受到高频率的大小变化,由于滑链错配 导致重复单元的增加或减少。这些重复蛋白的功能和表型 尺寸变化的后果是未知的。在鼠病原体肺支原体中, Vsa蛋白调节支原体的生长特性(菌落大小变化),血细胞吸附, 和对补体溶解的敏感性。我们的长期目标是了解 支原体目前的建议的目标是研究的功能和致病意义, Vsa尺寸变化。包括M.肺具有细胞外基质。我们提出 该基质由Vsa蛋白组成,并用于保护支原体免受补体的侵害。 目的1是通过电子显微镜检查基质,以确定其是否由Vsa蛋白组成, 并确定它是否是补体的屏障。Vsa蛋白可能会影响 支原体和宿主细胞,以及Vsa是否调节支原体对 吞噬作用将在目标2中进行检查。在目标3中,Vsa大小变化的致病意义将是 通过比较细胞产生大(许多串联重复)或小(很少重复)的能力来研究 Vsa蛋白在免疫活性细胞和补体系统中定植和致病的能力 缺陷小鼠这些研究的结果将阐明高度重复的蛋白质在支原体感染中的作用。 疾病它们还将提供对其他微生物中重复蛋白质功能的深入了解, 对公共卫生很重要的包括导致疟疾、肺结核和各种细菌的病原体。 肺炎通过了解重复蛋白质在疾病过程中的作用,预计 将制定更好的措施来控制这些重要的人类病原体的感染。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KEVIN F DYBVIG其他文献

KEVIN F DYBVIG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KEVIN F DYBVIG', 18)}}的其他基金

Mycoplasma Polysaccharides and Control of Infection
支原体多糖与感染控制
  • 批准号:
    8532448
  • 财政年份:
    2012
  • 资助金额:
    $ 31.18万
  • 项目类别:
Mechanisms of Mycoplasmal Disease Pathogenesis
支原体疾病发病机制
  • 批准号:
    6865025
  • 财政年份:
    2005
  • 资助金额:
    $ 31.18万
  • 项目类别:
Mechanisms of Mycoplasmal Disease Pathogenesis
支原体疾病发病机制
  • 批准号:
    8512647
  • 财政年份:
    2005
  • 资助金额:
    $ 31.18万
  • 项目类别:
Tandemly Repetitive Proteins in Mycoplasmas
支原体中的串联重复蛋白
  • 批准号:
    7740176
  • 财政年份:
    2005
  • 资助金额:
    $ 31.18万
  • 项目类别:
Mechanisms of Mycoplasmal Disease Pathogenesis
支原体疾病发病机制
  • 批准号:
    8701213
  • 财政年份:
    2005
  • 资助金额:
    $ 31.18万
  • 项目类别:
Mechanisms of Mycoplasmal Disease Pathogenesis
支原体疾病发病机制
  • 批准号:
    7024978
  • 财政年份:
    2005
  • 资助金额:
    $ 31.18万
  • 项目类别:
Tandemly Repetitive Proteins in Mycoplasmas
支原体中的串联重复蛋白
  • 批准号:
    7154096
  • 财政年份:
    2005
  • 资助金额:
    $ 31.18万
  • 项目类别:
Mechanisms of Mycoplasmal Disease Pathogenesis
支原体疾病发病机制
  • 批准号:
    7189109
  • 财政年份:
    2005
  • 资助金额:
    $ 31.18万
  • 项目类别:
Mechanisms of Mycoplasmal Disease Pathogenesis
支原体疾病发病机制
  • 批准号:
    8038799
  • 财政年份:
    2005
  • 资助金额:
    $ 31.18万
  • 项目类别:
Mechanisms of Mycoplasmal Disease Pathogenesis
支原体疾病发病机制
  • 批准号:
    7382546
  • 财政年份:
    2005
  • 资助金额:
    $ 31.18万
  • 项目类别:

相似海外基金

The role of alveolar macrophages and regulatory pathways in post-transplant lung inflammation.
肺泡巨噬细胞和调节途径在移植后肺部炎症中的作用。
  • 批准号:
    23K08315
  • 财政年份:
    2023
  • 资助金额:
    $ 31.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
MICA: Key mechanisms underlying inhaled GM-CSF's enhancement of phagocytosis and bacterial clearance by human alveolar macrophages.
MICA:吸入 GM-CSF 增强人肺泡巨噬细胞吞噬作用和细菌清除的关键机制。
  • 批准号:
    MR/X005046/1
  • 财政年份:
    2023
  • 资助金额:
    $ 31.18万
  • 项目类别:
    Research Grant
Analysis of pathogenic alveolar macrophages which release IL-1alpha in response to fine particles.
分析响应细颗粒物释放 IL-1α 的致病性肺泡巨噬细胞。
  • 批准号:
    23H03154
  • 财政年份:
    2023
  • 资助金额:
    $ 31.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Glutamine Metabolism in Alveolar Macrophages following Influenza A Infection
甲型流感感染后肺泡巨噬细胞的谷氨酰胺代谢
  • 批准号:
    10607319
  • 财政年份:
    2023
  • 资助金额:
    $ 31.18万
  • 项目类别:
The function and regulation of tissue resident alveolar macrophages turnover by host and environmental factors during homeostasis and in infections
稳态和感染期间宿主和环境因素对组织驻留肺泡巨噬细胞周转的功能和调节
  • 批准号:
    471247
  • 财政年份:
    2022
  • 资助金额:
    $ 31.18万
  • 项目类别:
    Fellowship Programs
Using a Lung on Chip Device to Study Alveolar Macrophages as Intracellular Reservoirs for Staphylococcus aureus
使用肺芯片装置研究肺泡巨噬细胞作为金黄色葡萄球菌的细胞内储库
  • 批准号:
    485971
  • 财政年份:
    2022
  • 资助金额:
    $ 31.18万
  • 项目类别:
    Studentship Programs
Analysis of innate immune response of alveolar macrophages and epithelial-mesenchymal transition of alveolar epithelial cells
肺泡巨噬细胞的先天免疫反应和肺泡上皮细胞的上皮间质转化分析
  • 批准号:
    22K06698
  • 财政年份:
    2022
  • 资助金额:
    $ 31.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Cholesterol crystal-mediated inflammation in alveolar macrophages: an emerging role inidiopathic lung fibrosis?
胆固醇晶体介导的肺泡巨噬细胞炎症:在特发性肺纤维化中的新兴作用?
  • 批准号:
    462596862
  • 财政年份:
    2021
  • 资助金额:
    $ 31.18万
  • 项目类别:
    WBP Position
Elucidation of idiopathic pneumonia syndrome: Angiotensin 2 activates alveolar macrophages
特发性肺炎综合征的阐明:血管紧张素 2 激活肺泡巨噬细胞
  • 批准号:
    21K16251
  • 财政年份:
    2021
  • 资助金额:
    $ 31.18万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Establishment of novel macrophage cell lines to study the pathogenesis of respiratory bacterial pathogens in lung alveolar macrophages
建立新型巨噬细胞系以研究肺泡巨噬细胞中呼吸道细菌病原体的发病机制
  • 批准号:
    NC/V001019/1
  • 财政年份:
    2021
  • 资助金额:
    $ 31.18万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了